700.25 24.80 (3.67%)

33.63% Fall from 52W High

44,320 NSE+BSE Volume

NSE 13 Mar, 2025 3:31 PM (IST)



Board Meetings - Thyrocare Technologies Ltd.

The latest board meeting for Thyrocare Technologies Ltd. took place on 23 Jan 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
23 Jan 2025 Quarterly Results -
23 Oct 2024 Quarterly Results -
23 Jul 2024 Quarterly Results -
14 May 2024 Audited Results & Final Dividend -
01 Feb 2024 Quarterly Results -
31 Oct 2023 Quarterly Results -
01 Aug 2023 Quarterly Results -
23 May 2023 Audited Results -
07 Apr 2023 Interim Dividend -
03 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
01 Aug 2022 Quarterly Results -
29 Apr 2022 Audited Results & Dividend -
12 Feb 2022 Quarterly Results -
13 Nov 2021 Quarterly Results -
12 Aug 2021 Quarterly Results -
08 May 2021 Audited Results & Final Dividend -
30 Jan 2021 Quarterly Results & 2nd Interim Dividend -
28 Oct 2020 Quarterly Results & Interim Dividend -
10 Sep 2020 Others -
31 Jul 2020 Quarterly Results & Interim Dividend -
23 May 2020 Audited Results, Final Dividend & ESOP -
01 Feb 2020 Quarterly Results & Interim Dividend -
07 Nov 2019 Quarterly Results & Interim Dividend -
10 Aug 2019 Quarterly Results -
13 Jun 2019 Others inter alia, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the WoS of the Co.
18 May 2019 Audited Results, Dividend & ESOP -
09 Feb 2019 Quarterly Results & Interim Dividend -
03 Nov 2018 Quarterly Results -
11 Aug 2018 Quarterly Results -
04 Aug 2018 Buy Back of Shares -
28 Apr 2018 Audited Results & Final Dividend -
03 Feb 2018 Quarterly Results & Interim Dividend -
09 Dec 2017 Quarterly Results & Interim Dividend -
12 Aug 2017 Quarterly Results -
09 May 2017 Audited Results, Dividend & ESOP -
24 Mar 2017 Others Reappointed Dr. A Velumani as Managing Director & CEO for period of three Years.
28 Jan 2017 Quarterly Results & Interim Dividend -
24 Oct 2016 Quarterly Results -
27 Aug 2016 General -
22 Jul 2016 Quarterly Results -
11 Jun 2016 Audited Results & Final Dividend Granting of Employee Stock Options for the financial year ended March 31, 2016.